Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02535338 |
| Title | Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | United States | Details | |
| Los Angeles General Medical Center | Los Angeles | California | 90033 | United States | Details | |
| USC / Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
| Keck Medical Center of USC Pasadena | Pasadena | California | 91105 | United States | Details | |
| University of California Davis Comprehensive Cancer Center | Sacramento | California | 95817 | United States | Details | |
| City of Hope South Pasadena | South Pasadena | California | 91030 | United States | Details |